Browse by Series:

FDA Acts Against Companies Selling Illegal Cancer Treatments and Clearance on Scalp Cooling System

Roy Herbst, MD
Published: Friday, Apr 28, 2017



Roy Herbst, MD, of Yale Cancer Center, reports on the FDA acting against companies illegally selling cancer treatments, an FDA clearance on a second scalp cooling system, promising phase III trials in breast cancer, and early findings with immunotherapy in liver cancer.
Slider Left
Slider Right


Roy Herbst, MD, of Yale Cancer Center, reports on the FDA acting against companies illegally selling cancer treatments, an FDA clearance on a second scalp cooling system, promising phase III trials in breast cancer, and early findings with immunotherapy in liver cancer.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Key Questions for the Use of Immunotherapy Throughout the Disease Continuum for NSCLC in an Era of Rapid DevelopmentSep 29, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing GlioblastomaSep 29, 20182.0
Publication Bottom Border
Border Publication
x